Bayer Aktiengesellschaft: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
August 08, 2022 at 01:49 am EDT
Share
DGAP Voting Rights Announcement: Bayer Aktiengesellschaft
Bayer Aktiengesellschaft: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
08.08.2022 / 07:47
Dissemination of a Voting Rights Announcement transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
Notification of Major Holdings
1. Details of issuer
Name:
Bayer Aktiengesellschaft
Street:
Kaiser-Wilhelm-Allee 1
Postal code:
51373
City:
Leverkusen Germany
Legal Entity Identifier (LEI):
549300J4U55H3WP1XT59
2. Reason for notification
X
Acquisition/disposal of shares with voting rights
Acquisition/disposal of instruments
Change of breakdown of voting rights
Other reason:
3. Details of person subject to the notification obligation
Legal entity: The Goldman Sachs Group, Inc. City of registered office, country: Wilmington, DE, United States of America (USA)
4. Names of shareholder(s)
holding directly 3% or more voting rights, if different from 3.
5. Date on which threshold was crossed or reached:
03 Aug 2022
6. Total positions
% of voting rights attached to shares (total of 7.a.)
% of voting rights through instruments (total of 7.b.1 + 7.b.2)
Total of both in % (7.a. + 7.b.)
Total number of voting rights pursuant to Sec. 41 WpHG
New
0.31 %
4.68 %
4.99 %
982424082
Previous notification
0.36 %
4.66 %
5.02 %
/
7. Details on total positions a. Voting rights attached to shares (Sec. 33, 34 WpHG)
ISIN
Absolute
In %
Direct (Sec. 33 WpHG)
Indirect (Sec. 34 WpHG)
Direct (Sec. 33 WpHG)
Indirect (Sec. 34 WpHG)
US0727303028
0
259395
0 %
0.03 %
DE000BAY0017
0
2791694
0 %
0.28 %
Total
3051089
0.31 %
b.1. Instruments according to Sec. 38 (1) no. 1 WpHG
Type of instrument
Expiration or maturity date
Exercise or conversion period
Voting rights absolute
Voting rights in %
Right To Recall
Open
2492556
0.25 %
Right Of Use
Open
1945857
0.20 %
Call Warrant
18.02.2025
64789
0.01 %
Forward
25.01.2023
7192
0.0007 %
Call Option
20.12.2024
4735485
0.48 %
Future
16.09.2022
3121753
0.32 %
Total
12367632
1.26 %
b.2. Instruments according to Sec. 38 (1) no. 2 WpHG
Type of instrument
Expiration or maturity date
Exercise or conversion period
Cash or physical settlement
Voting rights absolute
Voting rights in %
Future
19.12.2031
Cash
14926742
1.52 %
Forward
20.12.2024
Cash
838238
0.09 %
Call Warrant
31.12.2030
Cash
2371329
0.24 %
Call Option
31.03.2035
Cash
6706696
0.68 %
Put Option
20.12.2030
Cash
4556182
0.46 %
Put Option
15.12.2023
Physical
3027131
0.31 %
Swap
29.07.2032
Cash
1145281
0.12 %
Total
33571599
3.42 %
8. Information in relation to the person subject to the notification obligation
Person subject to the notification obligation is not controlled nor does it control any other undertaking(s) that directly or indirectly hold(s) an interest in the (underlying) issuer (1.).
X
Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity:
Name
% of voting rights (if at least 3% or more)
% of voting rights through instruments (if at least 5% or more)
Total of both (if at least 5% or more)
The Goldman Sachs Group, Inc.
%
%
%
GSAM Holdings LLC
%
%
%
NNIP Holdings LLC
%
%
%
NNIP UK Holdings I Ltd
%
%
%
NNIP UK Holdings II Ltd
%
%
%
NNIP Holdings I B.V. / NNIP Holdings II B.V.
%
%
%
NN Investment Partners Holdings B.V.
%
%
%
-
%
%
%
The Goldman Sachs Group, Inc.
%
%
%
GSAM Holdings LLC
%
%
%
Goldman Sachs Asset Management, L.P.
%
%
%
Goldman Sachs Asset Management International Holdings L.L.C.
%
%
%
Goldman Sachs Asset Management Co., Ltd.
%
%
%
-
%
%
%
The Goldman Sachs Group, Inc.
%
%
%
GS Global Markets, Inc.
%
%
%
Goldman Sachs Finance Corp International Ltd
%
%
%
-
%
%
%
The Goldman Sachs Group, Inc.
%
%
%
Goldman Sachs Bank USA
%
%
%
Goldman Sachs Bank Europe SE
%
%
%
-
%
%
%
The Goldman Sachs Group, Inc.
%
%
%
Goldman Sachs (UK) L.L.C.
%
%
%
Goldman Sachs Group UK Limited
%
%
%
Goldman Sachs International Bank
%
%
%
-
%
%
%
The Goldman Sachs Group, Inc.
%
%
%
GS Finance Corp.
%
%
%
-
%
%
%
The Goldman Sachs Group, Inc.
%
%
%
Goldman Sachs (UK) L.L.C.
%
%
%
Goldman Sachs Group UK Limited
%
%
%
Goldman Sachs International
%
%
%
-
%
%
%
The Goldman Sachs Group, Inc.
%
%
%
IMD Holdings LLC
%
%
%
United Capital Financial Partners, Inc.
%
%
%
United Capital Financial Advisers, LLC
%
%
%
-
%
%
%
The Goldman Sachs Group, Inc.
%
%
%
Goldman Sachs Non-US Americas Holdings LLC
%
%
%
Goldman Sachs Non-US Americas Holdings II LLC
%
%
%
GSEM Bermuda Holdings, L.P.
%
%
%
GS Equity Markets, L.P.
%
%
%
-
%
%
%
The Goldman Sachs Group, Inc.
%
%
%
Murray Street Corporation
%
%
%
Sphere Fundo De Investimento Multimercado - Investimento No Exterior Credito Privado
%
%
%
Sphere Fund
%
%
%
-
%
%
%
The Goldman Sachs Group, Inc.
%
%
%
Folio Financial, Inc.
%
%
%
Folio Investments Inc.
%
%
%
-
%
%
%
The Goldman Sachs Group, Inc.
%
%
%
Goldman Sachs & Co. LLC
%
%
%
-
%
%
%
The Goldman Sachs Group, Inc.
%
%
%
The Goldman Sachs Trust Company, National Association
%
%
%
The Goldman Sachs Trust Company of Delaware
%
%
%
-
%
%
%
The Goldman Sachs Group, Inc.
%
%
%
Goldman Sachs Do Brasil Banco Multiplo S/A
%
%
%
9. In case of proxy voting according to Sec. 34 para. 3 WpHG
(only in case of attribution of voting rights in accordance with Sec. 34 para. 1 sent. 1 No. 6 WpHG)
Date of general meeting:
Holding total positions after general meeting (6.) after annual general meeting:
Proportion of voting rights
Proportion of instruments
Total of both
%
%
%
10. Other explanatory remarks:
Date
05 Aug 2022
08.08.2022 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows:
- agrochemicals (48.8%): herbicides, fungicides, insecticides, etc.;
- pharmaceutical products (38%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.;
- OTC products and nutritional supplements (12.7%);
- other (0.5%).
Net sales are distributed geographically as follows: Germany (5.1%), Switzerland (1.2%), Europe-Middle East-Africa (23.2%), the United States (30.6%), North America (3.5%), China (7.6%), Asia-Pacific (10%), Brazil (10.4%) and Latin America (8.4%).
Bayer Aktiengesellschaft: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution